Financials
Financial year 2025
Revenue
€ 345,246
▼ 3% vs 2024
Profit
Healthy€ 123,950
▼ 94% vs 2024
Debts
Low€ 656,413
▼ 31% vs 2024
Blue Eagle Invest from Beerse, company number BE0476067387, closed financial year 2025 with a result of € 123,950 after tax. For that financial year Blue Eagle Invest recorded revenue of € 345,246 and equity of € 13.4 million. Compared with financial year 2024, the result moved from € 2.1 million to € 123,950. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
What happened at Blue Eagle Invest?
What happened at Blue Eagle Invest in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Blue Eagle Consult BV stepped down as director. NBB
- VANDECRUYS MANAGEMENT BV stepped down as director. NBB
- Nicolas Jansen stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 123,950 (▼ 94% vs 2024). Source: NBB ↗
- Blue Eagle Consult BV became a director. NBB
- VANDECRUYS MANAGEMENT BV became a director. NBB
- Nicolas Jansen became a director. NBB
- New establishment in Beerse. KBO
In short
From € 2.6 million profit in 2021 to € 123,950 profit in 2025.
Paid € 6,384 in corporate taxes since 2021.
Best year ever: 2021, with € 2.6 million profit.
Paid out € 500,000 in dividends to the owners in total.
A new publication or filing at Blue Eagle Invest? We notify you, reason included.
Follow Blue Eagle InvestNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Energia Pharma Services, 100% of Blue Eagle Immo NV, 100% of Dafra Pharma GmbH, 100% of Lux Pharma AG, 100% of Dafra Immo NV and 100% of Dafra Pharma ltd itself.
Directors
According to the 2025 annual accounts
Managing director · represented by Bruno Jansen
since 2023 · until 2030
Director · represented by Eduard Vandecruys
Also active at: Energia Pharma Services
since 2018 · until 2030
since 2018 · until 2030
Establishments
Establishment units
Physical locations of this company
Torenlaan 14
2340 Beerse
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
Details
- Company number
- 0476.067.387
- VAT number
- BE 0476.067.387
- Registered office
- Torenlaan 14, 2340 Beerse
- Names & denominations
- Blue Eagle Invest
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 13 November 2001
- Peppol
- Active · Active since 12 Sept 2025
- Contact
- +32475912920
- Activities · NACE
Activiteiten van holdings
Managementactiviteiten van holdings
Holdings